Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoer Kechuanling is a traditional Chinese medicine (TCM) formulation used primarily for the treatment of cough and asthma symptoms in children. It is commonly available as an oral liquid or granule. The formula typically contains a combination of herbal ingredients such as ephedra (ma huang), honeysuckle, bitter almond, isatis root, and licorice. Its mechanism of action is based on TCM principles—releasing lung qi, clearing heat, relieving cough, and expelling phlegm. Xiaoer Kechuanling is indicated for respiratory conditions like bronchitis and common cold in pediatric populations[1][4][7]. The product has been approved for use in China but may not be registered or authorized in other countries[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiaoer kechuanling.